Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 17031
Country/Region: Haiti
Year: 2013
Main Partner: Foundation for Innovative New Diagnostics
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $300,000

Foundation for Innovative New Diagnostics (FIND) implements activities that strengthen the quality of laboratory services through the implementation of two key projects in Haiti supported by a coag with CDC:

1.

Piloting Genexpert: FIND is working with CDC and the national lab to support the implementation and piloting the use of Xpert® MTB/RIF in Haiti for improving the case detection of TB or MDR-TB. FIND provides training and on-site supervision and monitoring during early implementation and also makes recommendations for national policy for scale-up of new technology.

2.

TB microscopy External Quality Assurance (EQA): FIND leads the development of a TB microscopy EQA manual and standard operating procedures and report forms, in close collaboration with LNSP and ASM. The EQA program will incorporate a blinded re-checking system, use of control slides by microscopy laboratories, on-site supervision and panel testing.

Funding for Laboratory Infrastructure (HLAB): $300,000

Foundation for Innovative New Diagnostics (FIND) implements activities that strengthen the quality of laboratory services through the implementation of two key projects in Haiti supported by a coag with CDC:

1.

Piloting Genexpert: FIND is working with CDC and the national lab to support the implementation and piloting the use of Xpert® MTB/RIF in Haiti for improving the case detection of TB or MDR-TB. FIND provides training and on-site supervision and monitoring during early implementation and also makes recommendations for national policy for scale-up of new technology.

2.

TB microscopy External Quality Assurance (EQA): FIND leads the development of a TB microscopy EQA manual and standard operating procedures and report forms, in close collaboration with LNSP and ASM. The EQA program will incorporate a blinded re-checking system, use of control slides by microscopy laboratories, on-site supervision and panel testing.